Sanofi-aventis, Covance form decade long R&D alliance
As per the agreements, Covance expects to provide drug development services to Sanofi-aventis, with estimated payments ranging from about $1.2bn to $2.2bn. However, Sanofi-aventis will sell its Porcheville,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.